IL290250A - Targeted gene therapy to treat neurological diseases - Google Patents
Targeted gene therapy to treat neurological diseasesInfo
- Publication number
- IL290250A IL290250A IL290250A IL29025022A IL290250A IL 290250 A IL290250 A IL 290250A IL 290250 A IL290250 A IL 290250A IL 29025022 A IL29025022 A IL 29025022A IL 290250 A IL290250 A IL 290250A
- Authority
- IL
- Israel
- Prior art keywords
- gene therapy
- neurological diseases
- targeted gene
- treat neurological
- treat
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962881540P | 2019-08-01 | 2019-08-01 | |
PCT/US2020/044598 WO2021022208A1 (en) | 2019-08-01 | 2020-07-31 | Targeted gene therapy to treat neurological diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
IL290250A true IL290250A (en) | 2022-04-01 |
Family
ID=72145498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL290250A IL290250A (en) | 2019-08-01 | 2022-01-31 | Targeted gene therapy to treat neurological diseases |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4007609A1 (de) |
IL (1) | IL290250A (de) |
WO (1) | WO2021022208A1 (de) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US6342390B1 (en) | 1994-11-23 | 2002-01-29 | The United States Of America As Represented By The Secretary Of Health And Human Services | Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
MA44546B1 (fr) * | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
JP7364468B2 (ja) * | 2017-02-28 | 2023-10-18 | ザ ペン ステイト リサーチ ファウンデーション | 血流の途絶に起因する神経損傷の治療のための機能性ニューロンの再生 |
-
2020
- 2020-07-31 WO PCT/US2020/044598 patent/WO2021022208A1/en active Application Filing
- 2020-07-31 EP EP20758033.3A patent/EP4007609A1/de active Pending
-
2022
- 2022-01-31 IL IL290250A patent/IL290250A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP4007609A1 (de) | 2022-06-08 |
WO2021022208A1 (en) | 2021-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246712A1 (zh) | 神經刺激治療疾病及病症 | |
IL288574A (en) | Oligonucleotides and methods for use in the treatment of neurological diseases | |
IL284554A (en) | Structures for gene therapy to treat Wilson's disease | |
IL279918A (en) | Gene therapy vectors for the treatment of Danon disease | |
ZA201903003B (en) | Treatment of neurological diseases | |
IL285238A (en) | Gene therapy vectors for the treatment of Danon disease | |
EP4076422A4 (de) | Verfahren zur verbesserung von neurologischen erkrankungen und störungen | |
SG11202101819QA (en) | Gene therapy for the treatment of galactosemia | |
GB202114972D0 (en) | Gene therapy | |
EP3413898A4 (de) | Verwendung von trehalose zur behandlung von neurologischen erkrankungen | |
HK1253299A1 (zh) | 一種通過基因治療治療眼疾病的改進方法 | |
EP4055033A4 (de) | Kombinationstherapie zur behandlung von hirnkrebs | |
GB201914034D0 (en) | Treatment of neurological disorders | |
EP4267196A4 (de) | Behandlung von neurologischen erkrankungen | |
GB202003618D0 (en) | Gene Therapy | |
IL290250A (en) | Targeted gene therapy to treat neurological diseases | |
IL282361A (en) | Treatment for neurological diseases | |
EP3966323A4 (de) | Gezielte therapie | |
GB202003109D0 (en) | Gene therapy | |
GB202002202D0 (en) | Gene therapy | |
IL287098A (en) | Genetic variants associated with treatment response in neurological disorders | |
GB202005321D0 (en) | Gene therapy treatment | |
GB201909438D0 (en) | Treatment of diseases | |
GB201706662D0 (en) | Treatment of neurological diseases | |
IL310017A (en) | RETGC gene therapy |